Vanguard Group Inc Pacific Biosciences Of California, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 26,606,485 shares of PACB stock, worth $47.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,606,485
Previous 26,789,552
0.68%
Holding current value
$47.6 Million
Previous $263 Million
62.03%
% of portfolio
0.0%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding PACB
# of Institutions
293Shares Held
253MCall Options Held
1.42MPut Options Held
1.18M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33.3MShares$59.6 Million0.89% of portfolio
-
Black Rock Inc. New York, NY23.4MShares$41.9 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA17.6MShares$31.5 Million9.04% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.12.8MShares$23 Million0.03% of portfolio
-
Nikko Asset Management Americas, Inc.12.8MShares$23 Million0.48% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $402M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...